相关实验视频

Updated: Feb 28, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

前列腺素E₂诱导树突细胞功能障碍在皮肤参与的乳腺癌

Jiawen Wang^1,2,3, Xiaoming Zhong^1,2, Xu Liu^1,2

¹Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory of RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China.

Cell death & disease

|February 25, 2026

概括

前列腺素E2 (PGE2) 在乳腺癌皮肤病变中损害树突细胞 (DC) 功能. 抑制PGE2恢复DC激活,改善T细胞反应,减少皮肤的参与,提供一种潜在的治疗策略.

科学领域:

免疫学免疫学免疫学
皮肤病学皮肤病学
在瘤学瘤学.

背景情况:

皮肤参与乳腺癌的预后不好,治疗选择有限.
皮肤树突细胞 (DCs) 对免疫平衡至关重要,但它们在乳腺癌皮肤病变中的作用尚不清楚.
了解皮肤病变中的DC功能对于开发新疗法至关重要.

研究的目的:

调查皮肤DCs在乳腺癌皮肤参与中的作用.
阐明皮肤损伤中DC功能障碍背后的机制.
探索针对乳腺癌皮肤病变的DC功能治疗策略.

主要方法:

对乳腺癌患者皮肤组织中免疫细胞透的分析.
转录组分析和初级皮肤DCs的体外测定.
损伤性和非损伤性皮肤的代谢概况.
在小鼠模型中体内抑制前列腺素E2 (PGE2).

主要成果:

在乳腺癌患者的皮肤损伤中观察到DC的数量减少和激活.
损伤皮肤的皮肤DCs通过皮肤的抗原处理和T淋巴细胞初始化受损.
损伤皮肤中增加的PGE2水平抑制了DC激活;PGE2抑制恢复了DC和CD8+T细胞的激活.
PGE2水平与DC透有负相关性;低的PGE2和高的DC激活与更好的患者结果有关.

结论:

在乳腺癌的皮肤参与中,PGE2诱导了DC功能障碍.
准PGE2可以恢复DC激活和T细胞反应.
抑制PGE2是一种有前途的治疗方法,用于管理乳腺癌的皮肤参与.

更多相关视频

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...